RCT Comparing Immunosuppressive Regimens in Elderly Renal Transplant Recipients

PHASE4Active, not recruitingINTERVENTIONAL
Enrollment

374

Participants

Timeline

Start Date

July 29, 2019

Primary Completion Date

June 30, 2025

Study Completion Date

December 31, 2026

Conditions
Renal Transplant RecipientsElderly PatientsImmunosuppression
Interventions
DRUG

low dose tacrolimus in combination with everolimus

a low exposure Tacrolimus once-daily (Envarsus®) regimen in combination with Everolimus will be evaluated in elderly transplant recipients

DRUG

standard dose tacrolimus with mycophenolate mofetil

A standard Tacrolimus once-daily (Envarsus) regimen in combination with Everolimus will be evaluated in elderly transplant recipients

Trial Locations (7)

Unknown

Leuven University Hospital, Leuven

Amsterdam UMC, Amsterdam

UMCG, Groningen

LUMC, Leiden

Radboud University Hospital, Nijmegen

Erasmus MC, Rotterdam

UMCU, Utrecht

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Radboud University Medical Center

OTHER

collaborator

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER

collaborator

Amsterdam UMC, location VUmc

OTHER

collaborator

UMC Utrecht

OTHER

collaborator

Leiden University Medical Center

OTHER

collaborator

Erasmus Medical Center

OTHER

collaborator

Universitaire Ziekenhuizen KU Leuven

OTHER

lead

University Medical Center Groningen

OTHER

NCT03797196 - RCT Comparing Immunosuppressive Regimens in Elderly Renal Transplant Recipients | Biotech Hunter | Biotech Hunter